- Messages
- 24,222
- Reaction score
- 4,443
- Points
- 288
As Bayer confronts mounting Roundup losses, all eyes on Philadelphia trial
Dec 4 (Reuters) - With Bayer (BAYGn.DE) facing investor pressure to resolve thousands of lawsuits over its Roundup weedkiller after being hit with $2 billion in verdicts in recent weeks, all eyes are on a trial wrapping up in Philadelphia.Plaintiffs have won the last four trials over their claims that the product causes cancer, each time securing a larger verdict. Those losses ended a nine-trial winning streak for Bayer, shattering investor and company hopes that the worst of the Roundup litigation was over.
Read the rest:

As Bayer confronts mounting Roundup losses, all eyes on Philadelphia trial
Plaintiffs have won the last four trials over their claims that the weedkiller causes cancer, ending a nine-trial winning streak for Bayer.